Article
Evolution of Nitrogen-Based Alkylating Anticancer Agents
2021-02-19
Abstract excerpt
Despite the significant progress in anticancer drug development over recent years, there is a vital need for newer agents with unique, but still effective, mechanisms of action in order to treat the disease, particularly the highly aggressive and drug-resistant types. Alkylating agents, in particular nitrogen-based alkylators, are commonly used to treat hematological and solid malignancies; they exert their antine...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fcdda27c-0e5d-5497-a424-acf37f379f4f
- DOI
- 10.3390/pr9020377
